Ethic Inc.

Position in KRYS — Krystal Biotech, Inc.

CIK 1780570 NEW YORK, NY

Position in KRYS

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$448,234

+$147,033 QoQ

Shares Held

1,206

+3.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#255

of 419 holders

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ethic Inc. holds $40,271,041 across 35 Biotechnology names. KRYS ranks #16 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	20,947	$10,405,003
2	REGN	Regeneron Pharmaceuticals, Inc.	16,069	$10,019,664
3	ARGX	Argenx SE	4,376	$4,059,921
4	IONS	Ionis Pharmaceuticals Inc	31,679	$2,511,827
5	CYTK	Cytokinetics Inc	18,965	$1,615,628
6	ALNY	Alnylam Pharmaceuticals, Inc.	5,172	$1,556,927
7	MRNA	Moderna, Inc.	15,694	$1,099,050
8	INBX	Inhibrx Biosciences, Inc.	9,345	$885,438

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$448,234	1,206	+3.4%	Shares	Sole	2026-07-29
2026-03-31	$301,201	1,166	+21.1%	Shares	Sole	2026-04-27
2025-12-31	$237,418	963	-32.7%	Shares	Sole	2026-02-03
2025-03-31	$258,009	1,431	+25.3%	Shares	Sole	2025-05-13
2024-09-30	$207,878	1,142	-10.3%	Shares	Sole	2024-11-13
2024-06-30	$233,773	1,273	+11.5%	Shares	Sole	2024-08-13
2024-03-31	$203,196	1,142	-31.1%	Shares	Sole	2024-05-13
2023-12-31	$205,691	1,658	-10.0%	Shares	Sole	2024-02-14
2023-09-30	$213,788	1,843	-20.5%	Shares	Sole	2023-11-14
2023-06-30	$272,133	2,318	-11.8%	Shares	Sole	2023-08-14
2022-12-31	$208,269	2,629	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.